Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

7792 ARTÍCULOS , VIENDO DEL 2131 AL 2145

A systematic review of the effectiveness of digital cognitive assessments of cognitive impairment in Parkinson's disease

Craig SN, Dempster M, Curran D, Cuddihy AM, Lyttle N.

Appl Neuropsychol Adult. 2025 Feb 1:1-13. doi: 10.1080/23279095.2025.2454983. Online ahead of print.

Correction: Revolutionizing our understanding of Parkinson's disease: Dr. Heinz Reichmann's pioneering research and future research direction

Tanaka M, Vécsei L.

J Neural Transm (Vienna). 2025 Feb 1. doi: 10.1007/s00702-025-02878-3. Online ahead of print.

Dopaminergic responsiveness and dopaminergic challenge tests of Parkinson's disease: a systematic review and meta-analysis

Kou W, Cai H, Cui Y, Zhu J, Li S, Yang C, Chen H, Feng T.

J Neurol. 2025 Feb 1;272(2):176. doi: 10.1007/s00415-025-12894-8.

Lasting Impact: Exploring the Brain Mechanisms that Link Traumatic Brain Injury to Parkinson's Disease

Edwards S, Corrigan F, Collins-Praino L.

Mol Neurobiol. 2025 Jun;62(6):7421-7444. doi: 10.1007/s12035-025-04706-x. Epub 2025 Feb 1.

Pilot screening for prodromal Parkinson's disease in post-9/11 Veterans with probable rapid eye movement sleep behavior disorder

Jones MB, Broadway D, White T, Jackson GR, Singh S, Li R, St Louis EK, Marsh LE, Jorge RE.

Parkinsonism Relat Disord. 2025 Mar;132:107309. doi: 10.1016/j.parkreldis.2025.107309. Epub 2025 Jan 26.

Psychedelics in neuroinflammation: Mechanisms and therapeutic potential

de Deus JL, Maia JM, Soriano RN, Amorim MR, Branco LGS.

Prog Neuropsychopharmacol Biol Psychiatry. 2025 Mar 20;137:111278. doi: 10.1016/j.pnpbp.2025.111278. Epub 2025 Jan 31.

Quantification of cinpanemab (BIIB054) binding to α-synuclein in cerebrospinal fluid of phase 1 single ascending dose samples

Liu Y, Yang M, Fraser K, Graham D, Weinreb PH, Weihofen A, Hirst WD, Cedarbaum JM, Pepinsky B.

J Pharmacol Exp Ther. 2025 Jan;392(1):100003. doi: 10.1124/jpet.124.002199. Epub 2024 Nov 22.

Emerging non-invasive MRI techniques for glymphatic system assessment in neurodegenerative disease

Botta D, Hutuca I, Ghoul EE, Sveikata L, Assal F, Lövblad KO, Kurz FT.

J Neuroradiol. 2025 May;52(3):101322. doi: 10.1016/j.neurad.2025.101322. Epub 2025 Jan 31.

Exploring how PRIME-Parkinson care is implemented and whether, how and why it produces change, for who and under what conditions: a protocol for an embedded process evaluation within the PRIME-UK randomised controlled trial

Lloyd K, Tenison E, Smith S, Lithander F, Kidger J, Brant H, Redwood S, Ben-Shlomo Y, Henderson EJ.

BMJ Open. 2025 Feb 2;15(1):e086353. doi: 10.1136/bmjopen-2024-086353.

Innate and adaptive immunity in neurodegenerative disease

Huang Y, Zhang G, Li S, Feng J, Zhang Z.

Cell Mol Life Sci. 2025 Feb 2;82(1):68. doi: 10.1007/s00018-024-05533-4.

Investigation of All Disease-Relevant Lysine Acetylation Sites in α-Synuclein Enabled by Non-canonical Amino Acid Mutagenesis

Shimogawa M, Li MH, Park GSH, Ramirez J, Lee H, Watson PR, Sharma S, Lin Z, Peng C, Lee VM, Garcia BA, Christianson DW, Rhoades E, Eliezer D, Petersson EJ.

bioRxiv [Preprint]. 2025 Aug 22:2025.01.21.634178. doi: 10.1101/2025.01.21.634178.

Phosphoproteome modifications and cortical circuit dysfunction are linked to the early-stage progression of alpha-synuclein aggregation

Dutta S, Hensel JA, Scott AN, Mohallem R, Rossitto LM, Khan HF, Johnson T, Ferreira CR, Diehl LA, Marmolejo JF, Chen X, Jayant K, Aryal UK, Volpicelli-Daley L, Rochet JC.

bioRxiv [Preprint]. 2025 Jun 5:2025.01.24.634820. doi: 10.1101/2025.01.24.634820.

Alpha synuclein and inflammaging

Putnam GL, Maitta RW.

Heliyon. 2025 Jan 15;11(2):e41981. doi: 10.1016/j.heliyon.2025.e41981. eCollection 2025 Jan 30.

Therapeutic targeting of obesity-induced neuroinflammation and neurodegeneration

Zeng J, Cheong LYT, Lo CH.

Front Endocrinol (Lausanne). 2025 Jan 17;15:1456948. doi: 10.3389/fendo.2024.1456948. eCollection 2024.

Electroconvulsive Therapy for Treatment-Resistant Depression in a Patient With Wolff-Parkinson-White Syndrome: A Case Report and Literature Review

Gutiérrez-Alzate MP, López-Ospino S, Suárez-Chacón AM, Coral-Sánchez GT, Acero-González ÁR.

J ECT. 2025 Sep 1;41(3):218-220. doi: 10.1097/YCT.0000000000001107. Epub 2025 Jan 28.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias